Wall Street To Pharma: Strike A Deal On Drug Pricing And Resolve Uncertainty About Reform
Executive Summary
Pricing policies aimed at lowering Medicare Part B costs should be ‘relatively easy’ to accomplish but they wouldn’t be as effective in satisfying industry critics as reforms in Part D, securities analyst Geoffrey Porges says.